691 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Tallman
    Tallman
  5. Zelenetz
    Zelenetz
  6. Moskowitz
    Moskowitz
  7. Berman
    Berman
  8. Steinherz
    Steinherz
  9. Andreeff
    Andreeff
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)
  7. Lymphoma (86)
  8. Sloan Kettering Institute Faculty (82)
  9. GSK Faculty (75)
  10. Pediatrics, Department of (75)
  1. "cytarabine"
Formats
  1. Journal Article (637)
  2. Review (20)
  3. Conference Paper (19)
  4. Research Letter (6)
  5. Correspondence (3)
  6. Editorial (2)
  7. Meeting Abstract (2)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)

More Groups

People
  1. Lisa De Angelis (53)
  2. Martin Tallman (42)
  3. Joachim Yahalom (39)
  4. Lauren Abrey (38)
  5. Peter Steinherz (34)
  6. Andrew Zelenetz (33)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (17)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (45)
  2. Blood (41)
  3. Cancer (29)
  4. Leukemia (27)
  5. Bone Marrow Transplantation (25)
  6. Leukemia and Lymphoma (23)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. Nature Publishing Group (67)
  3. American Society of Hematology (52)
  4. Springer (52)
  5. American Society of Clinical Oncology (48)
  6. Lippincott Williams & Wilkins (38)

More Publishers

Results (691)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study
    Journal Article

    Van Den Neste, E.; Schmitz, N.; Mounier, N.; Gill, D.; Linch, D.; Trneny, M.; Milpied, N.; Radford, J.; Ketterer, N.; Shpilberg, O.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Cost-effectiveness analysis of treating acute promyelocytic leukemia patients with arsenic trioxide and retinoic acid in the United States
    Journal Article

    Tallman, M.; Lo-Coco, F.; Barnes, G.; Kruse, M.; Wildner, R.; Martin, M.; Mueller, U.; Tang, B.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® diffuse large B-cell lymphoma
    Journal Article

    Dabaja, B. S.; Advani, R.; Hodgson, D. C.; Dhakal, S.; Flowers, C. R.; Ha, C. S.; Hoppe, B. S.; Mendenhall, N. P.; Metzger, M. L.; Plastaras, J. P.; more...
    American Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
    Journal Article

    Walter, R. B.; Othus, M.; Paietta, E. M.; Racevskis, J.; Fernandez, H. F.; Lee, J. W.; Sun, Z.; Tallman, M. S.; Patel, J.; Gönen, M.; more...
    Leukemia (2015)

    Fulltext@MSK | Save
  • Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
    Lancet Oncology (2015)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 13th International Conference on Malignant Lymphoma: Commentary
    Journal Article

    Moskowitz, C. H.
    Clinical Advances in Hematology & Oncology (2015)

    Fulltext@MSK | Save
  • High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells
    Journal Article

    Pera, B.; Calvo-Vidal, M. N.; Ambati, S.; Jordi, M.; Kahn, A.; Díaz, J. F.; Fang, W.; Altmann, K. H.; Cerchietti, L.; Moore, M. A. S.
    Cancer Letters (2015)

    Fulltext@MSK | Save
  • Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity
    Journal Article

    Sousa, F. G.; Matuo, R.; Tang, S. W.; Rajapakse, V. N.; Luna, A.; Sander, C.; Varma, S.; Simon, P. H. G.; Doroshow, J. H.; Reinhold, W. C.; more...
    DNA Repair (2015)

    Fulltext@MSK | Save
  • High-dose chemotherapy and autologous stem cell transplant in older patients with lymphoma
    Journal Article

    Lahoud, O. B.; Sauter, C. S.; Hamlin, P. A.; Dahi, P. B.
    Current Oncology Reports (2015)

    Fulltext@MSK | Save
  • Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia - Results of a phase I dose-escalation study
    Journal Article

    DiPersio, J. F.; Erba, H. P.; Larson, R. A.; Luger, S. M.; Tallman, M. S.; Brill, J. M.; Vuagniaux, G.; Rouits, E.; Sorensen, J. M.; Zanna, C.
    Clinical Lymphoma, Myeloma and Leukemia (2015)

    Fulltext@MSK | Save